Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements

Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients.

Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its relevance for patients, future research perspectives, collection of  tissue specimens, and the role of advocates in shaping public policy discussions.

Advocacy in Action at the 2012 European Society for Medical Oncology (ESMO) Congress in Vienna was made possible, in part, by:

Daiichi-Sankyo  - EPS Full ColorJanssen_Professional_4farbig_RGBLilly logo